Post Exercise Substrate Oxidation, Appetite and Energy Intakes in Overweight/Obese Postmenopausal Women (EScAPE)
NCT ID: NCT04364061
Last Updated: 2020-04-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2019-11-01
2020-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
HIIE and Abdominal Fat Mass in DT2 Postmenopausal Women
NCT02352246
High-Intensity Interval or Concurrent Exercise on Oxidative Stress and Inflammation in Obese Women
NCT07302191
High-Intensity Interval Training and Intermittent Fasting on Body Composition and Physical Performance in Active Women
NCT04404413
Females, Aging, Metabolism, and Exercise
NCT01712230
Upper-body High-intensity Interval Training and Mixed Meal Responses
NCT04277091
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Using a randomized crossover design, 12 postmenopausal women completed 3 cycling exercises at 6-days intervals:
i) Moderate Intensity Continuous Exercise (MICE) which consisted of 35 min cycling at 60-65% theorical Peak Heart Rate (thPHR) ii) High Intensity Interval Exercise 1 (HIIE 1) 60 cycles of speeding up for 8 s at 80-90%thPHR followed by pedaling slowly for 12 s (20min) iii) High Intensity Interval Exercise 2 (HIIE 2) which consisted of repeated 10 x 1min at 80-90% thPHR followed by pedaling slowly for 1min.
Substrate oxidation (CHO and FAT) were measured at rest and 2h- post exercise. Enjoyment, perceived exertion and appetite were recorded and post-exercise energy intakes were assessed over 24h.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Women with overweight or obesity
Moderate Intensity Continuous Exercise
Participant completed a moderate intensity continuous cycling exercise (MICE) during 35 min at 60-65% thPHRmax
High-Intensity Interval Exercise (1)
Participant completed a high-intensity interval cycling exercise (HIIE 1) during 20min with 60 cycles of speeding up for 8s and pedaling slowly for 12s at 80-90% thPHRmax
High-Intensity Interval Exercise (2)
Participant completed a high-intensity interval cycling exercise (HIIE 2) during 20min with 10 x 1-min bouts at 80-90% thPHRmax, separated by 1-min recovery bouts
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Moderate Intensity Continuous Exercise
Participant completed a moderate intensity continuous cycling exercise (MICE) during 35 min at 60-65% thPHRmax
High-Intensity Interval Exercise (1)
Participant completed a high-intensity interval cycling exercise (HIIE 1) during 20min with 60 cycles of speeding up for 8s and pedaling slowly for 12s at 80-90% thPHRmax
High-Intensity Interval Exercise (2)
Participant completed a high-intensity interval cycling exercise (HIIE 2) during 20min with 10 x 1-min bouts at 80-90% thPHRmax, separated by 1-min recovery bouts
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* with overweight or obesity (BMI \> 25 kg/m2 and ≤ 40 kg/m2)
Exclusion Criteria
* painful joints,
* taking hormone replacement therapy,
* taking B-blockers.
50 Years
75 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CREPS Auvergne Rhône-Alpes / Vichy
UNKNOWN
Laboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques et Pathologiques
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Claire MOREL, Dr
Role: PRINCIPAL_INVESTIGATOR
CREPS Auvergne Rhône-Alpes / Vichy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CREPS Auvergne Rhône-Alpes / Vichy
Bellerive-sur-Allier, Allier, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB00012476-2020-24-03-50
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.